MIDAS VERDICT:

Headlam was hit hard when the pandemic erupted last March but the group hunkered down, adapted to new ways of working and used the time to invest in future growth. These efforts should pay off this year and beyond. At £3.90, the shares are a buy. Over the longterm, there is the promise of an attractive dividend income too.